support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

View:
format_list_bulletedgrid_view

05/16/2022

CHEPLAPHARM acquires rights to CMV medicine
Press releases
Read morechevron_right

04/29/2022

CHEPLAPHARM continues profitable growth track in 2021 as well
Press releases
Read morechevron_right

03/21/2022

Significant and sustainable site expansion
Press releases
Read morechevron_right

03/01/2022

CHEPLAPHARM acquires additional oncology drugs
Press releases
Read morechevron_right

02/23/2022

Jens Rothstein hands over his CFO role to Kia Parssanedjad
Press releases
Read morechevron_right

02/11/2022

CHEPLAPHARM announces successful pricing of Term Loan B
Investor Relations
Read morechevron_right

11/19/2021

CHEPLAPHARM continues strong Growth
Archive Press releases
Read morechevron_right

10/13/2021

CHEPLAPHARM signed deal
Press releases
Read morechevron_right

06/16/2021

CHEPLAPHARM invests in portfolio of anti-infectives
Press releases
Read morechevron_right

05/04/2021

CHEPLAPHARM continues on the road to success
Press releases
Read morechevron_right
Back to topexpand_less